[27-54-pm1] Clinical Pharmacy 4, Appropriate use of medicines

[27-54-pm1-09] Development of doxorubicin resistance by bardoxolone methyl, an Nrf2 activator, in MCF-7 cells

○Yuichiro Hori¹, Shuhei Fukuno¹, Momoka Yatsuda¹, Ann Maekawa¹, Yuichiro Nakano¹, Katsuhito Nagai¹ (1. Osaka Ohtani Univ.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.